Cahill Sponsors Leveraged Finance Fights Melanoma Benefit
Cahill is proud to sponsor the Leveraged Finance Fights Melanoma (LFFM) benefit on Wednesday, June 14 at the MoMA Sculpture Garden & Lobby. Each year, the LFFM benefit rallies over 1,000 professionals from across the leveraged finance, private equity, and investment communities to raise critical funds to advance life-saving melanoma research.
All proceeds from LFFM benefit the Melanoma Research Alliance (MRA). Since its founding in 2007, MRA has committed over $131 million – and leveraged an additional $415 million – in funding to advance melanoma research to end death and suffering due to the disease.
For more information, please click here.